Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.238
https://www.valueinhealthjournal.com/article/S1098-3015(17)30572-7/fulltext
Title :
Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30572-7&doi=10.1016/j.jval.2017.08.238
First page :
A440
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
217